| Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder J Zohar, D Amital, C Miodownik, M Kotler, A Bleich, RM Lane, C Austin Journal of clinical psychopharmacology 22 (2), 190-195, 2002 | 278 | 2002 |
| Evidence-based guideline: treatment of tardive syndromes: report of the Guideline Development Subcommittee of the American Academy of Neurology R Bhidayasiri, S Fahn, WJ Weiner, GS Gronseth, KL Sullivan, ... Neurology 81 (5), 463-469, 2013 | 252 | 2013 |
| L-theanine relieves positive, activation, and anxiety symptoms in patients with schizophrenia and schizoaffective disorder: an 8-week, randomized, double-blind, placebo … MS Ritsner, C Miodownik, Y Ratner, T Shleifer, M Mar, L Pintov, V Lerner The Journal of clinical psychiatry 71 (1), 10913, 2010 | 131 | 2010 |
| Vitamin B6 treatment for tardive dyskinesia: a randomized, double-blind, placebo-controlled, crossover study. V Lerner, C Miodownik, A Kaptsan, Y Bersudsky, I Libov, BA Sela, ... Journal of Clinical Psychiatry 68 (11), 1648-1654, 2007 | 123 | 2007 |
| Tardive dyskinesia (syndrome): current concept and modern approaches to its management PP Lerner, C Miodownik, V Lerner Psychiatry and clinical neurosciences 69 (6), 321-334, 2015 | 115 | 2015 |
| Vitamin B6 in the treatment of tardive dyskinesia: a double-blind, placebo-controlled, crossover study V Lerner, C Miodownik, A Kaptsan, H Cohen, M Matar, U Loewenthal, ... American Journal of Psychiatry 158 (9), 1511-1514, 2001 | 112 | 2001 |
| Vitamin B12 and folate serum levels in newly admitted psychiatric patients V Lerner, M Kanevsky, T Dwolatzky, T Rouach, R Kamin, C Miodownik Clinical Nutrition 25 (1), 60-67, 2006 | 106 | 2006 |
| Curcumin as an add-on to antidepressive treatment: a randomized, double-blind, placebo-controlled, pilot clinical study J Bergman, C Miodownik, Y Bersudsky, S Sokolik, PP Lerner, A Kreinin, ... Clinical neuropharmacology 36 (3), 73-77, 2013 | 105 | 2013 |
| Association between mental disorders, cognitive disturbances and vitamin D serum level: Current state PP Lerner, L Sharony, C Miodownik Clinical nutrition ESPEN 23, 89-102, 2018 | 73 | 2018 |
| Efficacy of piracetam in the treatment of tardive dyskinesia in schizophrenic patients: a randomized, double-blind, placebo-controlled crossover study. I Libov, C Miodownik, Y Bersudsky, T Dwolatzky, V Lerner Journal of Clinical Psychiatry 68 (7), 1031-1037, 2007 | 71 | 2007 |
| Vitamin B~ 6 Treatment in Acute Neuroleptic-Induced Akathisia: A Randomized, Double-Blind, Placebo-Controlled Study V Lerner, J Bergman, N Statsenko, C Miodownik Journal of Clinical Psychiatry 65 (11), 1550-1554, 2004 | 68 | 2004 |
| Serum levels of brain-derived neurotrophic factor and cortisol to sulfate of dehydroepiandrosterone molar ratio associated with clinical response to L-theanine as augmentation … C Miodownik, R Maayan, Y Ratner, V Lerner, L Pintov, M Mar, A Weizman, ... Clinical neuropharmacology 34 (4), 155-160, 2011 | 56 | 2011 |
| Vitamin B6 versus mianserin and placebo in acute neuroleptic-induced akathisia: a randomized, double-blind, controlled study C Miodownik, V Lerner, N Statsenko, T Dwolatzky, B Nemets, E Berzak, ... Clinical neuropharmacology 29 (2), 68-72, 2006 | 55 | 2006 |
| The retinoid X receptor agonist bexarotene relieves positive symptoms of schizophrenia: a 6-week, randomized, double-blind, placebo-controlled multicenter trial V Lerner, C Miodownik, A Gibel, P Sirota, I Bush, H Elliot, R Benatov, ... The Journal of clinical psychiatry 74 (12), 18230, 2013 | 54 | 2013 |
| Augmentation with amisulpride for schizophrenic patients nonresponsive to antipsychotic monotherapy V Lerner, J Bergman, A Borokhov, U Loewenthal, C Miodownik Clinical neuropharmacology 28 (2), 66-71, 2005 | 54 | 2005 |
| Vitamin B~ 6 as Add-On Treatment in Chronic Schizophrenic and Schizoaffective Patients: A Double-Blind, Placebo-Controlled Study V Lerner, C Miodownik, A Kaptsan, H Cohen, U Loewenthal, M Kotler Journal of Clinical Psychiatry 63 (1), 54-58, 2002 | 53 | 2002 |
| Vitamin B6 in treatment of tardive dyskinesia: a preliminary case series study V Lerner, A Kaptsan, C Miodownik, M Kotler Clinical neuropharmacology 22 (4), 241-243, 1999 | 52 | 1999 |
| Curcumin as add-on to antipsychotic treatment in patients with chronic schizophrenia: a randomized, double-blind, placebo-controlled study C Miodownik, V Lerner, N Kudkaeva, PP Lerner, A Pashinian, ... Clinical neuropharmacology 42 (4), 117-122, 2019 | 51 | 2019 |
| Bexarotene as add-on to antipsychotic treatment in schizophrenia patients: a pilot open-label trial V Lerner, C Miodownik, A Gibel, E Kovalyonok, T Shleifer, AB Goodman, ... Clinical neuropharmacology 31 (1), 25-33, 2008 | 49 | 2008 |
| Motor symptoms of schizophrenia: is tardive dyskinesia a symptom or side effect? A modern treatment V Lerner, C Miodownik Current psychiatry reports 13, 295-304, 2011 | 46 | 2011 |
